These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7308718)

  • 1. Concentration and excretion of contrast agents during oral cholecystography as measured by computed tomography in dogs.
    Hunter TB; Fon GT; Berk RN; Capp MP
    Gastrointest Radiol; 1981; 6(4):349-52. PubMed ID: 7308718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1977; 12(1):85-95. PubMed ID: 838560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and physiology of the biliary radiographic contrast materials.
    Berk RN; Loeb PM
    Semin Roentgenol; 1976 Jul; 11(3):147-56. PubMed ID: 133461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic excretion of cholecystopaques introduced into the canine jejunum.
    Menuck L; Amberg JR; Bates M
    Invest Radiol; 1977; 12(1):106-8. PubMed ID: 138663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors in the intestinal absorption of oral cholecystopaques.
    Amberg JR; Thompson WM; Golberger L; Williamson S; Alexander R; Bates M
    Invest Radiol; 1980; 15(6 Suppl):S136-41. PubMed ID: 7203915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective vs. objective evaluation of gallbladder opacification during oral cholecystography in comparative clinical trials: implications for studies involving visual assessment.
    Fon GT; Hunter TB; Berk RN; Patton DD; Capp MP
    Radiology; 1982 Jul; 144(2):277-80. PubMed ID: 7089280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.
    Loeb PM; Berk RN; Janes JO; Perkin L; Moore J
    Radiology; 1978 Feb; 126(2):395-401. PubMed ID: 341220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder density and iodine concentration in humans during oral cholecystography. A comparison of iopanoic acid and iopronic acid.
    Thompson WM; Meyers WC; Shaw M; Bates M; Johnson GA; Hedlund LW
    Invest Radiol; 1982; 17(6):621-8. PubMed ID: 6759456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology of oral cholecystography].
    Gaón D
    Acta Gastroenterol Latinoam; 1980; 10(3):231-41. PubMed ID: 7013405
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of cholecystokinin in radiographic opacification of the gallbladder.
    Herzog RJ; Nelson JA
    Invest Radiol; 1976 SEP-OCT; 11(5):440-7. PubMed ID: 977262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial of oral cholecystography using combinations of contrast agents and two consecutive doses.
    Thoeni RF; Moss AA
    Radiology; 1982 Jul; 144(2):271-5. PubMed ID: 7045975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cholangiography and cholecystography using sodium iopanoate.
    Koehler RE; Goldberg HI
    Invest Radiol; 1977; 12(3):267-72. PubMed ID: 863631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated dose cholecystography: a comparison between iopanoic acid and sodium ipodate.
    Reiner RG; Lawson MJ; Davies GT; Tucker WG; Mileski O; Read TR; Grant AK
    Clin Radiol; 1980 Nov; 31(6):667-9. PubMed ID: 7214807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic properties of a new oral contrast medium for cholecystography.
    Rosati G; De Micheli P; Schiantarelli P
    Acta Radiol Diagn (Stockh); 1972 May; 12(3):335-46. PubMed ID: 5045427
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of diarrhea on gallbladder opacification during oral cholecystography: comparison of two cholecystographic agents (author's transl)].
    Fukuda K; Nanjo M; Harada J; Sekiya T; Kanehira Y; Anno I; Takayama M; Watanabe H; Yamada T; Yamaguchi M; Tada S
    Rinsho Hoshasen; 1979 Mar; 24(3):379-84. PubMed ID: 547079
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasound-guided transhepatic computed tomography cholecystography in beagle dogs.
    Kim D; Park S; Kim C; Yoon S; Choi J
    J Vet Sci; 2019 Jul; 20(4):e37. PubMed ID: 31364322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of secretin on the hepatic excretion of telepaque.
    Berk RN; Dunn CR
    Radiology; 1972 Jun; 103(3):585-7. PubMed ID: 5022955
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.